1.
Iannazzo S, Santoni L, Saleri C, et al. [Cost-effectiveness analysis of peginterferon beta-1a in Italian relapsing remitting multiple sclerosis management]. Farmeconomia. Health Economics and Therapeutic Pathways. 2016;17(2S):13-36. https://doi.org/10.7175/fe.v17i2S.1230